Related Experiment Video

Updated: Jun 5, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

[Study of correlation factors with left ventricular hypertrophy during cardiac hypertrophy induced hypertension and

Hai-ying Li1, Zi-quan Liu, Chang-qing Tong

  • 1Department of physiology, Medical College of the Chinese People's Armed Police Forces, Tianjin 300162, China.

Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology
|January 7, 2011
PubMed

Insights

Hypertension, including systolic blood pressure (SBP), is linked to left ventricular hypertrophy (LVH). Cardiac neuropeptide Y (NPY) also correlates with LVH, but plasma NPY does not.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology

Context:

  • Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular morbidity and mortality.
  • Understanding the molecular and hemodynamic factors contributing to LVH is crucial for developing targeted therapies.

Purpose:

  • To investigate the relationship between hemodynamic parameters (systolic blood pressure [SBP], diastolic blood pressure [DBP], mean arterial pressure [MAP]) and neuropeptide Y (NPY) levels with left ventricular hypertrophy (LVH).
  • To explore these associations during both the development and regression of cardiac hypertrophy.

Summary:

  • Positive correlations were observed between SBP, DBP, MAP, and cardiac tissue NPY levels with the cardiac coefficient (left ventricular weight to body weight ratio [LVW/BW]).
  • No significant correlations were found between the cardiac coefficient and heart rate (HR) or plasma NPY levels.
  • SBP demonstrated a stronger correlation with LVW/BW compared to DBP.

Impact:

  • Findings suggest hypertension is a key factor in cardiac hypertrophy.
  • These results highlight the potential role of cardiac NPY in the pathogenesis of LVH.
  • The study provides insights into the complex interplay of hemodynamic and neuroendocrine factors in cardiac remodeling.
Abstract

More Related Videos

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...